The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Interventions for preventing oral mucositis for patients with cancer receiving treatment
Open accessAbstract
Comparison 1 Allopurinol versus placebo/no treatment, Outcome 1 Mucositis (any). . . . . . . .Analysis 1.2.Comparison 1 Allopurinol versus placebo/no treatment, Outcome 2 Mucositis (moderate plus severe). .Analysis 1.3.Comparison 1 Allopurinol versus placebo/no treatment, Outcome 3 Mucositis (severe). . . . . . .Analysis 2.1.Comparison 2 Aloe vera versus placebo, Outcome 1 Mucositis (moderate plus severe). . . . . . .Analysis 3.1.Comparison 3 Amifostine versus placebo/no treatment, Outcome 1 Mucositis (any). . . . . . . .Analysis 3.2.Comparison 3 Amifostine versus placebo/no treatment, Outcome 2 Mucositis (moderate plus severe). .Analysis 3.3.Comparison 3 Amifostine versus placebo/no treatment, Outcome 3 Mucositis (severe). . . . . . .Analysis 4.1.Comparison 4 Chlorhexidine versus placebo/no treatment, Outcome 1 Mucositis (any). . . . . . .Analysis 4.2.Comparison 4 Chlorhexidine versus placebo/no treatment, Outcome 2 Mucositis (moderate plus severe).Analysis 4.3.Comparison 4 Chlorhexidine versus placebo/no treatment, Outcome 3 Mucositis (severe). . . . . .Analysis 5.1.Comparison 5 Cryotherapy versus no treatment, Outcome 1 Mucositis (any). . . . . . . . . .Analysis 5.2.Comparison 5 Cryotherapy versus no treatment, Outcome 2 Mucositis (moderate plus severe). . . .Analysis 5.3.Comparison 5 Cryotherapy versus no treatment, Outcome 3 Mucositis (severe). . . . . . . . .Analysis 6.1.Comparison 6 Glutamine versus placebo, Outcome 1 Mucositis (any). . . . . . . . . . . . .Analysis 6.2.Comparison 6 Glutamine versus placebo, Outcome 2 Mucositis (moderate plus severe). . . . . . .Analysis 6.3.Comparison 6 Glutamine versus placebo, Outcome 3 Mucositis (severe). . . . . . . . . . . .Analysis 7.1.Comparison 7 G-CSF versus placebo or no treatment, Outcome 1 Mucositis (any). . . . . . . .Analysis 7.2.Comparison 7 G-CSF versus placebo or no treatment, Outcome 2 Mucositis (severe). . . . . . .Analysis 8.1.Comparison 8 GM-CSF versus no treatment/placebo, Outcome 1 Mucositis (any). . . . . . . .Analysis 8.2.Comparison 8 GM-CSF versus no treatment/placebo, Outcome 2 Mucositis (moderate plus severe). .Analysis 8.3.Comparison 8 GM-CSF versus no treatment/placebo, Outcome 3 Mucositis (severe). . . . . . .Analysis 9.1.Comparison 9 Honey versus control, Outcome 1 Mucositis (any). . . . . . . . . . . . . .Analysis 9.2.Comparison 9 Honey versus control, Outcome 2 Mucositis (moderate plus severe). . . . . . . .Analysis 9.3.Comparison 9 Honey versus control, Outcome 3 Mucositis (severe). . . . . . . . . . . . .Analysis 10.1.Comparison 10 Hydrolytic enzymes versus no treatment, Outcome 1 Mucositis (any). . . . . . .Analysis 10.2.Comparison 10 Hydrolytic enzymes versus no treatment, Outcome 2 Mucositis (moderate plus severe).Analysis 11.1.Comparison 11 Iseganan versus placebo, Outcome 1 Mucositis (moderate plus severe). . . . . . .Analysis 11.2.Comparison 11 Iseganan versus placebo, Outcome 2 Mucositis (severe). . . . . . . . . . . .Analysis 12.1.Comparison 12 Keratinocyte GF versus placebo, Outcome 1 Mucositis (any). . . . . . . . . .Analysis 12.2.Comparison 12 Keratinocyte GF versus placebo, Outcome 2 Mucositis (moderate plus severe). . . .Analysis 12.3.Comparison 12 Keratinocyte GF versus placebo, Outcome 3 Mucositis (severe). . . . . . . . .Analysis 13.1.Comparison 13 Laser versus no treatment, Outcome 1 Mucositis (any). . . . . . . . . . . .Analysis 13.2.Comparison 13 Laser versus no treatment, Outcome 2 Mucositis (moderate plus severe). . . . . .Analysis 13.3.Comparison 13 Laser versus no treatment, Outcome 3 Mucositis (severe). . . . . . . . . . .i Interventions for preventing oral mucositis for patients with cancer receiving treatment (Review)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Self-citationMoher, D., Schulz, K. F., Altman, D. G., & for the CONSORT Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00011 · Cited by 1,426
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., et al. (2004) · Cancer · doi:10.1002/cncr.20162 · Cited by 1,417
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040125 · Cited by 893
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3339 · Cited by 828
Rubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L. S., Fox, P. C., Cooksley, C., Sonis, S. T., et al. (2004) · Cancer · doi:10.1002/cncr.20163 · Cited by 820
Pyrhönen, S., Kuitunen, T., Nyandoto, P., & Kouri, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.114 · Cited by 789
Cited by
Preventing and Managing Toxicities of High-Dose Methotrexate
Howard, S. C., McCormick, J., Pui, C.-H., Buddington, R. K., & Harvey, R. D. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0164 · Cited by 929
Oral complications of cancer and cancer therapy: From cancer treatment to survivorship
Epstein, J. B., Thariat, J., Bensadoun, R., Barasch, A., Murphy, B. A., Kolnick, L., Popplewell, L., & Maghami, E. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21157 · Cited by 518
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Cinausero, M., Aprile, G., Ermacora, P., Basile, D., Vitale, M. G., Fanotto, V., Parisi, G., Calvetti, L., & Sonis, S. T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00354 · Cited by 290
Zecha, J. A. E. M., Raber-Durlacher, J. E., Nair, R. G., Epstein, J. B., Sonis, S. T., Elad, S., Hamblin, M. R., Barasch, A., Migliorati, C. A., Milstein, D. M. J., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3152-z · Cited by 262
Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
Aslani, N., Janbabaei, G., Abastabar, M., Meis, J. F., Babaeian, M., Khodavaisy, S., Boekhout, T., & Badali, H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-017-2916-5 · Cited by 114
Metadata
- Authors
- Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A.-M., Littlewood, A., McCabe, M. G., Meyer, S., Khalid, T., & Riley, P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2011-04-13
- Volume
- 2021
- Issue
- 3
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4253835683
- Cited by
- 262
- References
- 120
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interventions for preventing oral mucositis for patients with cancer receiving treatment. https://app.cochat.ai/papers/10.1002/14651858.cd000978.pub5
- The paper
- Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A.-M., Littlewood, A., McCabe, M. G., Meyer, S., Khalid, T., & Riley, P. (2011). Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000978.pub5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.